How AI Is Accelerating Recombinant Protein Engineering

Artificial intelligence (AI) is reshaping protein engineering by moving functional discovery beyond low throughput experimentation toward predictive, application-driven design. Recent advances in generative protein modeling and AI-guided sequence prediction help accelerate tailored recombinant protein development for highly specialized research and manufacturing environments.¹

Recombinant proteins play a critical role in drug development and several production processes ranging from biologics to cell therapies. However, producing structurally complex proteins ex vivo remains a significant challenge, often resulting in proteins with limited stability, short half-life, and inconsistent bioactivity. This creates barriers to reproducibility, scalability, and cost-effective manufacturing. Additionally, conventional evolutionary protein engineering methods often rely on iterative screening and selection workflows to identify proteins with desired functional and structural properties. These directed evolution-based engineering strategies can be time consuming and limited in predictive accuracy.¹

Predictive platforms help scientists improve key attributes and support biomanufacturing-ready recombinant protein engineering, cutting down on the need to screen thousands of variants manually, and homing in on key variants before the bench. For instance, scientists have used AI-guided tools to develop heat-stable cytokines that improve manufacturing consistency, salt-active nucleases that maintain performance in challenging reaction environments, and highly specific antibodies that reduce background noise in analytical assays.

Leveraging AI to integrate structural modeling, machine learning, and sequence-function prediction, platforms such as ACROBiosystems’ ACROAIx™ transform protein engineering and advance efficient cell-based manufacturing workflows. Developed with years of protein engineering expertise, ACROBiosystems uses this innovative platform to provide better recombinant proteins across different application and functions. By combining multiple core technologies, the platform enhances the efficiency and quality of protein development while also providing robust support for biopharmaceutical research and development.

Learn more about AI-guided protein engineering.